To investigate if DFX exerts its activity on acute leukemia samples in a p53-dependent manner, we analyzed the expression of well-known p53 target genes in our acute myeloid leukemia cell lines that are indeed characterized by a peculiar p53 genotype. This evidence concerns the gene TP53 and acute leukemia.